Levosulpiride + Rabeprazole
Composition
The formulation Contains enteric coated rabeprazole sodium and levosulpride sustained release as the active ingredients.
Indications
treatment of gastroesophageal reflux disease (GERD) and functional dyspepsia associated with gastric motility disorders.
Side effects
headache, dizziness, and gastrointestinal disturbances. Rare but serious side effects can include extrapyramidal symptoms and hypersensitivity reactions.
Precautions
Use with caution in patients with a history of neurological disorders or hypersensitivity reactions to other proton pump inhibitors or dopamine antagonists
Contraindications
Pregnancy, lactating women
Dosage and administration
Typically taken once daily
Countries
India, Russia
Available Forms
SR capsules
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai